Prophylactic mastectomy for women with BRCA1 and BRCA2 mutations -: Facts and controversy

被引：13

作者：

Eisen, A ^{[1
]}

Weber, BL

机构：

[1] McMaster Univ, Hamilton, ON L8N 3Z5, Canada

[2] Univ Penn, Philadelphia, PA 19104 USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2001年 / 345卷 / 03期

关键词：

D O I：

10.1056/NEJM200107193450309

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：207 / 208

页数：2

共 10 条

[1] Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk [J].

Brekelmans, CTM ;

Seynaeve, C ;

Bartels, CCM ;

Tilanus-Linthorst, MMA ;

Meijers-Heijboer, EJ ;

Crepin, CMG ;

van Geel, AN ;

Menke, M ;

Verhoog, LC ;

van den Ouweland, A ;

Obdeijn, IM ;

Klijn, JGM .

JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (04) :924-930

[2] Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 study [J].

Fisher, B ;

Costantino, JP ;

Wickerham, DL ;

Redmond, CK ;

Kavanah, M ;

Cronin, WM ;

Vogel, V ;

Robidoux, A ;

Dimitrov, N ;

Atkins, J ;

Daly, M ;

Wieand, S ;

Tan-Chiu, E ;

Ford, L ;

Wolmark, N .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (18) :1371-1388

[3] Long-term satisfaction and psychological and social function following bilateral prophylactic mastectomy [J].

Frost, MH ;

Schaid, DJ ;

Sellers, TA ;

Slezak, JM ;

Arnold, PG ;

Woods, JE ;

Petty, PM ;

Johnson, JL ;

Sitta, DL ;

McDonnell, SK ;

Rummans, TA ;

Jenkins, RB ;

Sloan, JA ;

Hartmann, LC .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 284 (03) :319-324

[4] Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer [J].

Hartmann, LC ;

Schaid, DJ ;

Woods, JE ;

Crotty, TP ;

Myers, JL ;

Arnold, PG ;

Petty, PM ;

Sellers, TA ;

Johnson, JL ;

McDonnell, SK ;

Frost, MH ;

Jenkins, RB .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (02) :77-84

[5]

HARTMANN LC, 2000, P AM ASSOC CANC RES, V41, P222

[6] The psychosocial impact of bilateral prophylactic mastectomy: prospective study using questionnaires and semistructured interviews [J].

Hatcher, MB ;

Fallowfield, L ;

A'Hern, R .

BRITISH MEDICAL JOURNAL, 2001, 322 (7278) :76-79

[7]

KING MC, 2001, 37 ANN M AM SOC CLIN

[8] Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. [J].

Meijers-Heijboer, H ;

van Geel, B ;

van Putten, WLJ ;

Henzen-Logmans, SC ;

Seynaeve, C ;

Menke-Pluymers, MBE ;

Bartels, CCM ;

Verhoog, LC ;

van den Ouweland, AMW ;

Niermeijer, MF ;

Brekelmans, CTM ;

Klijn, JGM .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (03) :159-164

[9] Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers:: a case-control study [J].

Narod, SA ;

Brunet, JS ;

Ghadirian, P ;

Robson, M ;

Heimdal, K ;

Neuhausen, SL ;

Stoppa-Lyonnet, D ;

Lerman, C ;

Pasini, B ;

de los Rios, P ;

Weber, B ;

Lynch, H .

LANCET, 2000, 356 (9245) :1876-1881

[10] Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers [J].

Rebbeck, TR ;

Levin, AM ;

Eisen, A ;

Snyder, C ;

Watson, P ;

Cannon-Albright, L ;

Isaacs, C ;

Olopade, O ;

Garber, JE ;

Godwin, AK ;

Daly, MB ;

Narod, SA ;

Neuhausen, SL ;

Lynch, HT ;

Weber, BL .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (17) :1475-1479

← 1 →